Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2008-9-12
pubmed:abstractText
Previous reports have demonstrated that CD133(+) cells or CD44(+) cells might be cancer initiating cells (CIC) of colon cancer. However, the association between the two cell types is unclear. In this study, we evaluated the tumorigenicity of each population of human colon cancer divided by CD133 and CD44 using non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1534-4681
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2927-33
pubmed:meshHeading
pubmed-meshheading:18663533-Animals, pubmed-meshheading:18663533-Antigens, CD, pubmed-meshheading:18663533-Antigens, CD44, pubmed-meshheading:18663533-Butyrates, pubmed-meshheading:18663533-Cell Differentiation, pubmed-meshheading:18663533-Cell Proliferation, pubmed-meshheading:18663533-Colonic Neoplasms, pubmed-meshheading:18663533-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:18663533-Flow Cytometry, pubmed-meshheading:18663533-Gene Expression Regulation, Neoplastic, pubmed-meshheading:18663533-Glycoproteins, pubmed-meshheading:18663533-Humans, pubmed-meshheading:18663533-Mice, pubmed-meshheading:18663533-Mice, Inbred NOD, pubmed-meshheading:18663533-Mice, SCID, pubmed-meshheading:18663533-Neoplastic Stem Cells, pubmed-meshheading:18663533-Peptides, pubmed-meshheading:18663533-Tumor Markers, Biological, pubmed-meshheading:18663533-Xenograft Model Antitumor Assays
pubmed:year
2008
pubmed:articleTitle
CD133+CD44+ population efficiently enriches colon cancer initiating cells.
pubmed:affiliation
Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, 565-0871, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't